Search - tctmd.com

Displaying 841 - 860 of 2239

Sort: Relevancy | Date

News Daily News

CMS Advisory Panel Splits on TAVR Volume Requirements

Todd Neale

July 26, 2018

Story 2: STS Data: Mitral Valve Cases Are Fastest-Growing Surgical Intervention in North America

News Daily News

STS Data: Mitral Valve Cases Are Fastest-Growing CV Surgical Intervention in North America

L.A. McKeown

July 25, 2018

News Industry News

Boston Scientific Announces Agreement to Acquire Claret Medical, Inc.

July 24, 2018

News Daily News

TAVR’s Two-Surgeon Sign-off Rule Must Go, Experts Say

Shelley Wood

July 23, 2018

News Daily News

Sentinel Cerebral Embolic Protection Device Acquired by Boston Scientific

Shelley Wood

July 20, 2018

News Daily News

Updated TAVR Consensus Statement Keeps Volume Requirements but Shifts Focus to Quality

Todd Neale

July 18, 2018

News Daily News

No Harm Done: Foregoing Routine TEE and General Anesthesia in TAVR

Caitlin E. Cox

July 17, 2018

News Daily News

Valve-in-Valve TAVR Meets ‘Benchmark’ Set by Native-Valve Cases for Safety, Effectiveness

Caitlin E. Cox

July 16, 2018

News Daily News

Hemodynamic Deterioration Post-SAVR: Dysmetabolic Profile, Calcification Could Be Early Warning Signs

Caitlin E. Cox

July 10, 2018

News Daily News

Lp(a) Might Not Be Good at Predicting Incident CVD in Low-Risk Women

Yael L. Maxwell

July 09, 2018

News Daily News

CMS Taking Another Look at Volume Requirements for TAVR Programs

Todd Neale

June 28, 2018

News Industry News

Edwards Comments On CMS Initiation Of National Coverage Analysis For TAVR

June 28, 2018

Trade-offs Between Self-Expanding and Balloon-Expandable Valves in Very Large Annuli

Michael O'Riordan

June 26, 2018

News Industry News

Essential Medical Announces Positive Results from The Safe Manta Clinical Trial, The First Pivotal Trial for a Dedicated Large Bore Closure Device

June 25, 2018

News Conference News The Structural Heart Disease Summit 2018

SAFE-MANTA: Large-Bore Vascular Closure Device Achieves Fast Hemostasis With Few Complications

Michael O'Riordan

June 23, 2018

News Conference News The Structural Heart Disease Summit 2018

PORTICO I Postapproval Registry Outside the US Offers ‘Teaser’ for Pivotal Trial

Shelley Wood

June 23, 2018

News Conference News The Structural Heart Disease Summit 2018

High-Quality TAVR: Does a Minimum Volume Requirement Still Make Sense?

Michael O'Riordan

June 22, 2018

News Conference News The Structural Heart Disease Summit 2018

Data or Money: What’s Holding Back Cerebral Embolic Protection in TAVR?

Shelley Wood

June 21, 2018

News Conference News The Structural Heart Disease Summit 2018

Nearly 25% of AVR Patients Experience Anxiety or Depression in First Year

Michael O'Riordan

June 21, 2018

News Daily News

‘Failure to Rescue’ Doesn’t Fully Explain Higher Mortality at Lower-Volume TAVR Centers

Yael L. Maxwell

June 20, 2018

Advertisement

CMS Advisory Panel Splits on TAVR Volume Requirements

STS Data: Mitral Valve Cases Are Fastest-Growing CV Surgical Intervention in North America

Boston Scientific Announces Agreement to Acquire Claret Medical, Inc.

TAVR’s Two-Surgeon Sign-off Rule Must Go, Experts Say

Sentinel Cerebral Embolic Protection Device Acquired by Boston Scientific

Updated TAVR Consensus Statement Keeps Volume Requirements but Shifts Focus to Quality

No Harm Done: Foregoing Routine TEE and General Anesthesia in TAVR

Valve-in-Valve TAVR Meets ‘Benchmark’ Set by Native-Valve Cases for Safety, Effectiveness

Hemodynamic Deterioration Post-SAVR: Dysmetabolic Profile, Calcification Could Be Early Warning Signs

Lp(a) Might Not Be Good at Predicting Incident CVD in Low-Risk Women

CMS Taking Another Look at Volume Requirements for TAVR Programs

Edwards Comments On CMS Initiation Of National Coverage Analysis For TAVR

Trade-offs Between Self-Expanding and Balloon-Expandable Valves in Very Large Annuli

Essential Medical Announces Positive Results from The Safe Manta Clinical Trial, The First Pivotal Trial for a Dedicated Large Bore Closure Device

SAFE-MANTA: Large-Bore Vascular Closure Device Achieves Fast Hemostasis With Few Complications

PORTICO I Postapproval Registry Outside the US Offers ‘Teaser’ for Pivotal Trial

High-Quality TAVR: Does a Minimum Volume Requirement Still Make Sense?

Data or Money: What’s Holding Back Cerebral Embolic Protection in TAVR?

Nearly 25% of AVR Patients Experience Anxiety or Depression in First Year

‘Failure to Rescue’ Doesn’t Fully Explain Higher Mortality at Lower-Volume TAVR Centers

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content